Cargando…
TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer
TMEFF2 is a type I transmembrane protein with two follistatin (FS) and one EGF‐like domain over‐expressed in prostate cancer; however its biological role in prostate cancer development and progression remains unclear, which may, at least in part, be explained by its proteolytic processing. The extra...
Autores principales: | Gaweł‐Bęben, Katarzyna, Ali, Nazim, Ellis, Vincent, Velasco, Gloria, Poghosyan, Zaruhi, Ager, Ann, Knäuper, Vera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836882/ https://www.ncbi.nlm.nih.gov/pubmed/28762604 http://dx.doi.org/10.1002/cbin.10832 |
Ejemplares similares
-
ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells
por: Mattern, Jens, et al.
Publicado: (2019) -
TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease
por: Masood, Motasim, et al.
Publicado: (2020) -
Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
por: Posadas-Sánchez, Rosalinda, et al.
Publicado: (2022) -
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma
por: Schneider, Marc A., et al.
Publicado: (2022) -
CircTmeff1 Promotes Muscle Atrophy by Interacting with TDP‐43 and Encoding A Novel TMEFF1‐339aa Protein
por: Chen, Rui, et al.
Publicado: (2023)